First Republic Investment Management Inc. boosted its holdings in Danaher Corporation (NYSE:DHR) by 0.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 538,879 shares of the conglomerate’s stock after purchasing an additional 4,129 shares during the period. First Republic Investment Management Inc. owned about 0.08% of Danaher worth $46,224,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. ETRADE Capital Management LLC raised its stake in shares of Danaher by 5.1% during the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock valued at $1,610,000 after purchasing an additional 917 shares during the period. Honeywell International Inc. bought a new position in shares of Danaher during the 2nd quarter valued at about $25,317,000. Roundview Capital LLC increased its position in shares of Danaher by 2.0% during the 2nd quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock valued at $2,167,000 after purchasing an additional 502 shares during the last quarter. Eastern Bank increased its position in shares of Danaher by 4,291.1% during the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock valued at $10,802,000 after purchasing an additional 125,086 shares during the last quarter. Finally, Perkins Coie Trust Co increased its position in shares of Danaher by 2.0% during the 2nd quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock valued at $2,484,000 after purchasing an additional 586 shares during the last quarter. 76.32% of the stock is currently owned by institutional investors and hedge funds.

In related news, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total value of $11,671,620.96. Following the transaction, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 273,810 shares of company stock valued at $25,218,813. 12.20% of the stock is currently owned by company insiders.

Danaher Corporation (NYSE DHR) opened at $93.18 on Friday. The company has a market capitalization of $64,468.69, a P/E ratio of 23.83, a PEG ratio of 2.20 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a one year low of $77.45 and a one year high of $94.82.

Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.87 EPS. analysts expect that Danaher Corporation will post 3.99 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Thursday, December 28th. Danaher’s payout ratio is presently 16.52%.

Several research firms have weighed in on DHR. Cowen reiterated a “buy” rating and issued a $90.00 price objective on shares of Danaher in a report on Wednesday, October 4th. J P Morgan Chase & Co reiterated an “overweight” rating and issued a $95.00 price objective on shares of Danaher in a report on Friday, September 8th. Robert W. Baird increased their price objective on Danaher from $87.00 to $97.00 and gave the stock an “outperform” rating in a report on Friday, October 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a report on Thursday, October 5th. Finally, Goldman Sachs Group reiterated a “neutral” rating and issued a $83.00 price objective on shares of Danaher in a report on Tuesday, September 26th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $93.31.

WARNING: “Danaher Corporation (DHR) Shares Bought by First Republic Investment Management Inc.” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/danaher-corporation-dhr-shares-bought-by-first-republic-investment-management-inc/1753703.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.